Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Eli Lilly
LLY
|
$534M |
| 2 |
Amazon
AMZN
|
$432M |
| 3 |
Abbott
ABT
|
$420M |
| 4 |
Adobe
ADBE
|
$365M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$277M |
Top Sells
| 1 |
Sherwin-Williams
SHW
|
$472M |
| 2 |
Bank of America
BAC
|
$426M |
| 3 |
TE Connectivity
TEL
|
$399M |
| 4 |
Atlassian
TEAM
|
$364M |
| 5 |
Goldman Sachs
GS
|
$348M |
Sector Composition
| 1 | Technology | 32.59% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.8% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
IDEAYA Biosciences
IDYA
$2.38B
| $126M | 0.08% |
3,551,891
+1,828,731
| +106% | +$65.1M |
|
227
nVent Electric
NVT
$14.9B
| $126M | 0.08% |
2,134,783
+536,097
| +34% | +$31.7M |
|
|
SUM
228
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $126M | 0.08% |
3,279,352
-490
| -0% | -$18.8K |
|
229
Vertiv
VRT
$47.4B
| $122M | 0.07% |
2,550,367
+1,499,445
| +143% | +$72M |
|
230
Zurn Elkay Water Solutions
ZWS
$7.71B
| $122M | 0.07% |
4,150,678
+3,743
| +0.1% | +$110K |
|
231
S&P Global
SPGI
$164B
| $122M | 0.07% |
276,300
-206
| -0.1% | -$90.8K |
|
232
BellRing Brands
BRBR
$4.97B
| $121M | 0.07% |
2,186,770
-83,140
| -4% | -$4.61M |
|
233
Williams Companies
WMB
$69.9B
| $119M | 0.07% |
3,428,898
-469,741
| -12% | -$16.4M |
|
234
Aon
AON
$79.9B
| $119M | 0.07% |
409,018
-182,747
| -31% | -$53.2M |
|
235
Clarivate
CLVT
$2.96B
| $118M | 0.07% |
12,760,671
+170,827
| +1% | +$1.58M |
|
236
Agree Realty
ADC
$8.08B
| $117M | 0.07% |
1,866,184
+570,967
| +44% | +$35.9M |
|
237
EOG Resources
EOG
$64.4B
| $117M | 0.07% |
966,486
-36,883
| -4% | -$4.46M |
|
238
AstraZeneca
AZN
$253B
| $116M | 0.07% |
1,729,255
-114,859
| -6% | -$7.74M |
|
239
Legend Biotech
LEGN
$6.66B
| $112M | 0.07% |
1,865,157
+131,379
| +8% | +$7.91M |
|
240
Centene
CNC
$14.2B
| $111M | 0.07% |
1,495,067
-153,745
| -9% | -$11.4M |
|
241
Zai Lab
ZLAB
$3.42B
| $110M | 0.07% |
4,040,282
-202,944
| -5% | -$5.55M |
|
242
Autodesk
ADSK
$69.5B
| $108M | 0.06% |
441,891
-4,705
| -1% | -$1.15M |
|
243
Western Alliance Bancorporation
WAL
$10B
| $107M | 0.06% |
1,619,120
+339,505
| +27% | +$22.3M |
|
244
Encompass Health
EHC
$12.6B
| $106M | 0.06% |
1,593,359
+21,607
| +1% | +$1.44M |
|
245
UBS Group
UBS
$128B
| $106M | 0.06% |
3,406,328
+755,403
| +28% | +$23.4M |
|
246
Saia
SAIA
$8.34B
| $105M | 0.06% |
240,131
-24,898
| -9% | -$10.9M |
|
247
Maximus
MMS
$4.97B
| $103M | 0.06% |
1,228,711
-86,722
| -7% | -$7.27M |
|
248
NeoGenomics
NEO
$1.03B
| $103M | 0.06% |
6,348,613
-825,814
| -12% | -$13.4M |
|
249
Soleno Therapeutics
SLNO
$3.71B
| $102M | 0.06% |
2,523,897
+319,844
| +15% | +$12.9M |
|
250
Akero Therapeutics
AKRO
$3.58B
| $101M | 0.06% |
4,306,401
-180,325
| -4% | -$4.21M |
|